Please use this identifier to cite or link to this item: https://repository.southwesthealthcare.com.au/swhealthcarejspui/handle/1/3855
Journal Title: Mediation of Successful Reperfusion Effect through Infarct Growth and Cerebral Edema: A Pooled, Patient-Level Analysis of EXTEND-IA Trials and SELECT Prospective Cohort
Authors: Sarraj, Amrou
Pujara, Deep K.
Churilov, Leonid
Sitton, Clark W.
Ng, Felix
Hassan, Ameer E.
Abraham, Michael G.
Blackburn, Spiros L.
Sharma, Gagan
Yassi, Nawaf
Kleinig, Timothy
Shah, Darshan
Wu, Teddy Y.
Tekle, Wondwossen G.
Budzik, Ronald F.
Hicks, William J., 2nd
Vora, Nirav
Edgell, Randall C
Haussen, Diogo
Ortega-Gutierrez, S.
Toth, Gabor
Maali, Laith
Abdulrazzak, Mohammad Ammar
Al-Shaibi, F.
AlMaghrabi, Tareq
Yogendrakumar, Vignan
Shaker, Faris
Mir, Osman
Arora, Ashish
Duncan, Kelsey
Sundararajan, Sophia
Opaskar, Amanda
Hu, Yin
Ray, Ashish
Sunshine, Jeffrey
Bambakidis, Nicholas
Martin-Schild, Sheryl
Hussain, Muhammad Shazam
Nogueira, Raul
Furlan, Anthony
Sila, Cathy A.
Grotta, James C.
Parsons, Mark
Mitchell, Peter J.
Davis, Stephen M.
Albers, Gregory W.
Campbell, Bruce C. V.
Select, EXTEND-IA EXTEND-IA TNK
EXTEND-IA TNK Investigators Part II
Keywords: Humans
Stroke
Brain Edema
Treatment Outcome
Prospective Studies
Brain Ischemia
Cerebral Infarction
Reperfusion
Endovascular Procedures
Issue Date: Apr-2023
Date Accessioned: 2023-04-24T02:44:23Z
Date Available: 2023-04-24T02:44:23Z
Accession Number: 36571388
Url: https://www.ncbi.nlm.nih.gov/pubmed/36571388
https://onlinelibrary.wiley.com/doi/full/10.1002/ana.26587
Description Affiliation: Department of Neurology, Case Western Reserve University, Cleveland, OH, USA.
Department of Neurology, University Hospitals Cleveland Medical Center, Cleveland, OH, USA.
Department of Neurology, Royal Melbourne Hospitals, University of Melbourne, Parkville, Victoria, Australia.
Department of Diagnostic and Interventional Radiology, UTHealth McGovern Medical School, Houston, TX, USA.
University of Texas Rio Grande Valley-Valley Baptist Medical Center, Harlingen, TX, USA.
Department of Neurology and Radiology, University of Kansas Medical Center, Kansas City, KS, USA.
Department of Neurosurgery, UTHealth McGovern Medical School, Houston, TX, USA.
Walter and Eliza Hall Institute of Medical Research, Population Health and Immunity, Parkville, Victoria, Australia.
Department of Neurology, Royal Adelaide Hospital, Adelaide, South Australia, Australia.
Department of Neurology, Gold Coast University Hospital, Southport, Queensland, Australia.
Department of Neurology, Christchurch Hospital, Christchurch, New Zealand.
Riverside Methodist Hospital, Colombia, OH, USA.
Department of Neurology, Saint Louis University, Saint Louis, MO, USA.
Department of Neurology, Emory University, Atlanta, GA, USA.
Department of Neurology, University of Iowa, Iowa City, IA, USA.
Department of Neurology, Cleveland Clinic, Cleveland, OH, USA.
Department of Neurology, University of Tabuk, Tabuk, Kingdom of Saudi Arabia.
Department of Neurology, Baylor Scott & White Health, Dallas, TX, USA.
Department of Neurology, Greensboro | Cone Health, Greensboro, NC, USA.
Department of Neurosurgery, University Hospitals Cleveland Medical Center, Cleveland, OH, USA.
Department of Neurology, Touro Infirmary and New Orleans East Hospital, New Orleans, LA, USA.
Department of Neurology, University of Pittsburgh Medical Center, Pittsburgh, PA, USA.
Department of Neurology, Memorial Hermann Hospital Texas Medical Center, Houston, TX, USA.
Department of Neurology, University of Newcastle, Newcastle, New South Wales, Australia.
Department of Radiology, Royal Melbourne Hospital-University of Melbourne, Parkville, Victoria, Australia.
Department of Neurology, Stanford University, Stanford, CA, USA.
Format Startpage: 793-804
Source Volume: 93
Issue Number: 4
Database: Medline
Notes: Ann Neurol. 2023 Apr;93(4):793-804. doi: 10.1002/ana.26587. Epub 2023 Jan 17.
DOI: 10.1002/ana.26587
Date: Apr
NLM
2023
Abstract: OBJECTIVE: Reperfusion therapy is highly beneficial for ischemic stroke. Reduction in both infarct growth and edema are plausible mediators of clinical benefit with reperfusion. We aimed to quantify these mediators and their interrelationship. METHODS: In a pooled, patient-level analysis of the EXTEND-IA trials and SELECT study, we used a mediation analysis framework to quantify infarct growth and cerebral edema (midline shift) mediation effect on successful reperfusion (modified Treatment in Cerebral Ischemia >/= 2b) association with functional outcome (modified Rankin Scale distribution). Furthermore, we evaluated an additional pathway to the original hypothesis, where infarct growth mediated successful reperfusion effect on midline shift. RESULTS: A total 542 of 665 (81.5%) eligible patients achieved successful reperfusion. Baseline clinical and imaging characteristics were largely similar between those achieving successful versus unsuccessful reperfusion. Median infarct growth was 12.3ml (interquartile range [IQR] = 1.8-48.4), and median midline shift was 0mm (IQR = 0-2.2). Of 249 (37%) demonstrating a midline shift of >/=1mm, median shift was 2.75mm (IQR = 1.89-4.21). Successful reperfusion was associated with reductions in both predefined mediators, infarct growth (beta = -1.19, 95% confidence interval [CI] = -1.51 to -0.88, p < 0.001) and midline shift (adjusted odds ratio = 0.36, 95% CI = 0.23-0.57, p < 0.001). Successful reperfusion association with improved functional outcome (adjusted common odds ratio [acOR] = 2.68, 95% CI = 1.86-3.88, p < 0.001) became insignificant (acOR = 1.39, 95% CI = 0.95-2.04, p = 0.094) when infarct growth and midline shift were added to the regression model. Infarct growth and midline shift explained 45% and 34% of successful reperfusion effect, respectively. Analysis considering an alternative hypothesis demonstrated consistent results. INTERPRETATION: In this mediation analysis from a pooled, patient-level cohort, a significant proportion (~80%) of successful reperfusion effect on functional outcome was mediated through reduction in infarct growth and cerebral edema. Further studies are required to confirm our findings, detect additional mediators to explain successful reperfusion residual effect, and identify novel therapeutic targets to further enhance reperfusion benefits. ANN NEUROL 2023;93:793-804.
URI: https://repository.southwesthealthcare.com.au/swhealthcarejspui/handle/1/3855
Journal Title: Annals of Neurology
Type: Journal Article
Appears in Collections:SWH Data Contributions

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Google Media

Google ScholarTM

Who's citing